Nanosonics Ltd
Research Nanosonics Ltd (NAN) on Bullrun: market cap AUD 861.60M, P/E 48.0. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNAN
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyAUD
- Market capAUD 861.60M
- P/E48.0
- Financial periodFY2025
- RevenueAUD 198.93M
- Revenue growth16.0%
- Net incomeAUD 20.68M
- Free cash flowAUD 35.26M
- Gross margin78.2%
Valuation Snapshot
latest market cap is AUD 861.60M; P/E is 48.0.
Peer valuation comparison
Latest P/E is 48x versus a Healthcare sector median of 24.61x (95.1% above).
Latest P/E is 48x versus a Australia median of 15.64x (206.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | AUD 198.93M | AUD 20.68M | AUD 35.26M | 78.2% | 0.07 | AUD 161.29M | AUD 7.69M | AUD 209.91M |
| FY2024 | AUD 171.56M | AUD 12.97M | AUD 20.27M | 78.1% | 0.04 | AUD 129.55M | AUD 9.30M | AUD 182.20M |
| FY2023 | AUD 167.52M | AUD 19.88M | AUD 19.74M | 78.9% | 0.06 | AUD 112.16M | AUD 10.72M | AUD 163.86M |
| FY2022 | AUD 119.73M | AUD 3.74M | -AUD 271.00K | 76.3% | 0.01 | AUD 94.51M | AUD 11.71M | AUD 138.69M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-03 | AUD 861.60M | 48.0 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Nanosonics Ltd
Nanosonics Limited engages in the manufacture and commercialization of infection control and decontamination products and related technologies in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. It offers trophon, an automated ultrasound probe high-level disinfection device built on hydrogen peroxide chemistry with integrated digital traceability solutions, as well as related consumables and accessories.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Nanosonics Ltd's market cap?
Nanosonics Ltd's market capitalization is AUD 861.60M.
What is Nanosonics Ltd's P/E ratio?
Nanosonics Ltd's price-to-earnings (P/E) ratio is 48.0.
What does Nanosonics Ltd do?
Nanosonics Limited engages in the manufacture and commercialization of infection control and decontamination products and related technologies in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. It offers trophon, an automated ultrasound probe high-level disinfection device built on hydrogen peroxide chemistry with integrated digital traceability solutions, as well as related consumables and accessories. The company also provides infection control and decontamination products and related technologies.